Morning Brief: Gold Gets Lift as Treasury Yield Push Weakens Dollar

The clearest transmission is in gold. Washington's attempt to contain long-dated Treasury yields has included foreign-exchange intervention in support of the Japanese yen, designed in part to keep Japanese investors in U.S. paper, and signals that the Treasury could buy long-dated bonds either with proceeds from short-dated bill sales or with funds from its Treasury General Account. That mix is described as worsening the risk-reward for Treasury investors amid rising U.S. debt levels and burnishing gold's appeal as a safe-haven asset. The policy announcements have also threatened to add dollar cash, fanned inflation fears and lowered U.S. real yields, strengthening gold as a currency-debasement hedge.

If the Federal Reserve lowers the average duration of its bond holdings as part of a balance-sheet overhaul, the analysis sees a 'Fed operation twist' flattening the Treasury yield curve further and making short-dollar positions against gold more profitable.

Treasury markets already reflect part of the move. A week after Treasury Secretary Scott Bessent's intervention, longer-dated yields are about 10-15 basis points lower. An 8% swing lower in oil prices since last week has helped the long end, while lower yields have pulled interest-rate volatility down and fed into calmer FX and equity volatility. The next tests are U.S. PCE inflation data, a $44bn 7-year note auction, and Friday's Jackson Hole speech from Federal Reserve Chair Kevin Warsh.

Oil's supply-risk premium is also cooling. Federal Reserve official Collins said disinflation remains the most likely outcome based on limited additional tariffs and progress on reopening the Strait of Hormuz. Lower fuel costs support consumer and transport margins, while the lower long-rate environment is supportive of duration-sensitive technology and real assets.

Rate expectations firmed in Australia after July consumer price inflation surprised to the upside and lifted the Australian dollar, a popular carry-trade target. A revised forecast now has the Reserve Bank of Australia raising its cash rate by 25 basis points in November.

In corporate news, Biohaven has licensed an epilepsy drug to South Korea's SK Biopharmaceuticals for up to $795 million.